Urine albumin-to-creatinine ratio test offers early detection of kidney damage in at-risk groups

A simple urine test called ACR is increasingly recognised as a vital tool for detecting early kidney damage, enabling timely intervention especially for people with diabetes or hypertension, before symptoms develop.

A simple urine test known as ACR is emerging as an important way to spot kidney damage before symptoms appear, particularly in people with diabetes or high blood pressure. According to the National Kidney Foundation, albumin in the urine can be an early and sensitive sign that the kidneys are not filtering properly, even when a patient feels well.

ACR, short for albumin-to-creatinine ratio, compares the amount of albumin, a blood protein, with creatinine in a single urine sample. The point of the test is to adjust for how diluted or concentrated the urine is, which makes it more reliable than looking at albumin alone. The kidney foundation says persistent protein in the urine is a key marker of chronic kidney disease.

The National Institute of Diabetes and Digestive and Kidney Diseases says the spot urine albumin-to-creatinine ratio, often called UACR, is used to diagnose and monitor kidney damage, especially in people with diabetes. It recommends yearly screening for people with type 1 diabetes after 5 years of disease and for people with type 2 diabetes. The institute also says a UACR above 30 mg/g is abnormal, with higher levels indicating greater kidney risk.

Cleveland Clinic notes that a normal result is below 30 mg/g, while readings from 30 to 299 mg/g suggest increased risk and readings of 300 mg/g or more may point to more serious kidney disease. The broader medical message is clear: kidney damage can begin quietly, and a basic urine test can give doctors a chance to intervene earlier, before the condition advances.

Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.